Spinal Cord Injuries: Clinical Trials

120 trials for Spinal Cord Injuries, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

120 completed. 120 Phase 2, 36 Phase 1, 17 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 2120Completed 120
Phase 136Completed 36
Phase 317Completed 17

Follow Spinal Cord Injuries: new trials by email Literature Review of Spinal Cord Injuries trials Research Report on Spinal Cord Injuries

Trials (filtered) newest first · largest first

All 120 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Effects of CBD/CBD-A Oral Extract on Resting-state EEG and Neuropathic Pain Symptoms After SCI
CBD/CBD-A, Placebo - SCI - Spinal Cord Injury, Neuropathic Pain
Phase 1 / Phase 2CompletedUniversity of Miami62025-06-162026-08-14
Treating Central Neuropathic Pain With Low Dose Naltrexone for People With Spinal Cord Injury
4.5mg daily dose of naltrexone - Central Neuropathic Pain, Spinal Cord Injury
Phase 2CompletedMedical College of Wisconsin112025-02-012026-11-02
Access-H20: Sensor-driven Smart Faucet Related Study
Water Faucet - Spinal Cord Injuries
Phase 2CompletedOld Dominion University232024-02-012026-05-22
NVG-291 in Spinal Cord Injury Subjects
NVG-291, Placebo Injection - Spinal Cord Injuries, Chronic Spinal Cord Injury
Phase 1 / Phase 2CompletedNervGen Pharma242023-08-082026-11-03
Remotely Delivered Cognitive Multisensory Rehabilitation for Sensory and Motor Recovery After Spinal Cord Injury
Remote CMR, Remote Exercise - Spinal Cord Injuries, Spinal Cord Diseases
Phase 2CompletedUniversity of Minnesota192023-06-012025-07-08
Study Testing Benefits of Ursolic Acid (UA) as a Countermeasure To Myopenia and Insulin Resistance in Chronic Spinal Cord Injury (SCI)
Ursolic Acid, Strength Training - Spinal Cord Injuries, Tetraplegia
Phase 2CompletedUniversity of Miami102023-03-272025-05-21
Cell Therapy for Chronic Traumatic Cervical Incomplete Spinal Cord Injury
WJ-MSC (XCEL-UMC-BETA), Placebo - Spinal Cord Injury Cervical
Phase 1 / Phase 2CompletedBanc de Sang i Teixits182021-10-132024-01-24
Effects of Electrical Stimulation and Vitamin D Supplementation on Bone Health Following Spinal Cord Injury.
NMES, Vitamin D, Passive movement - Spinal Cord Injury
Phase 2 / Phase 3CompletedVA Office of Research and Development62021-10-012026-01-23
Study to Assess the Efficacy and Safety of MT-3921 in Subjects With Acute Traumatic Cervical Spinal Cord Injury
MT-3921, Placebo - Spinal Cord Injury
Phase 2CompletedTanabe Pharma America, Inc.722021-08-272025-12-16
Effects of Rimonabant on Walking Abilities in Incomplete Spinal Cord Injury
Rimonabant - Spinal Cord Injuries
Phase 1 / Phase 2CompletedHospital Nacional de Parapléjicos de Toledo82021-05-122022-11-15
Romosozumab to Improve Bone Mineral Density and Architecture in Chronic SCI
Romosozumab, Denosumab, Placebo - Spinal Cord Injury (=3 Years), Sublesional Bone Loss Secondary to SCI
Phase 2CompletedVA Office of Research and Development362021-03-012026-09-21
Romosozumab in Women With Chronic SCI
Romosozumab, Alendronate - Osteoporosis, Bone Loss
Phase 2CompletedNorthwestern University122021-03-012025-09-24
Brivaracetam to Reduce Neuropathic Pain in Chronic Spinal Cord Injury
Brivaracetam, Placebo - Spinal Cord Injuries
Phase 1 / Phase 2CompletedUniversity of Minnesota242021-02-012025-10-14
Improving Ventilatory Capacity in Those With Chronic High Level SCI
Buspirone, Placebo - Spinal Cord Injuries
Phase 2CompletedSpaulding Rehabilitation Hospital132020-11-292025-09-18
Safety And Efficacy Study Of Intravenous (IV) Administration Of Elezanumab To Assess Change In Upper Extremity Motor Score (UEMS) In Adult Participants With Acute Traumatic Cervical Spinal Cord Injury (SCI)
Elezanumab, Placebo - Spinal Cord Injury (SCI)
Phase 2CompletedAbbVie602020-09-062026-02-11
Neuromodulation Techniques After SCI
EAW+SCES (exoskelton and spinal cord epidural stimulation), EAW+TS (exoskelton and transspinal stimulation) - Spinal Cord Injury
Phase 2CompletedVA Office of Research and Development42020-06-012026-04-28
Intravesical Lactobacillus to Reduce Urinary Symptoms After Spinal Cord Injury
Culturelle 10 Billion CFU Capsule (2 doses), Culturelle 10 Billion CFU Capsule (4 doses) - Spinal Cord Injuries, Neurogenic Bladder
Phase 2CompletedMedstar Health Research Institute1822020-06-012026-11-03
Clinical Trial to Evaluate Safety, Tolerability and Efficacy of NFX88 in SCI
NFX88 - 1, NFX88 - 2, NFX88 - 3 - Neuropathic Pain, Spinal Cord Injuries
Phase 2CompletedNeurofix S.L.442019-10-012022-12-02
Intravesical Glycosaminoglycan Instillation and Urinary Tract Infection in Acute Spinal Cord Injury
iAluRil® intravesical instillations - Spinal Cord Injuries
Phase 1 / Phase 2CompletedThe University of Western Australia102019-09-182021-05-03
Multimodality Intervention for Function and Metabolism in SCI
Testosterone Undecanoate, hybrid exercise - Spinal Cord Injuries
Phase 2CompletedBrigham and Women's Hospital842019-08-232026-05-07

Showing 20 of 120. Sign in to see all of them.

Narrower conditions

Quadriplegia (9)  ·  Neuralgia (7)  ·  Spinal Cord Diseases (7)  ·  Chronic Pain (6)  ·  Bone Diseases, Metabolic (5)  ·  Hypotension, Orthostatic (5)  ·  Neurologic Manifestations (5)  ·  Osteoporosis (5)  ·  Urinary Bladder, Neurogenic (5)  ·  Wounds and Injuries (5)  ·  Agnosia (4)  ·  Bone Diseases (4)  ·  Paraplegia (4)  ·  Urinary Tract Infections (4)

Broader conditions

Trauma, Nervous System (119)  ·  Central Nervous System Diseases (117)  ·  Nervous System Diseases (117)  ·  Wounds and Injuries (115)  ·  Spinal Cord Diseases (113)  ·  Pathological Conditions, Signs and Symptoms (46)  ·  Signs and Symptoms (45)  ·  Neurologic Manifestations (33)  ·  Pain (12)  ·  Nutritional and Metabolic Diseases (10)  ·  Autonomic Nervous System Diseases (8)  ·  Metabolic Diseases (8)  ·  Neuromuscular Diseases (8)  ·  Cardiovascular Diseases (7)  ·  Female Urogenital Diseases (7)

Interventions

Lithium Carbonate (4)  ·  Midodrine (4)  ·  Sodium Chloride (4)  ·  Buspirone (3)  ·  Cholecalciferol (3)  ·  NG-Nitroarginine Methyl Ester (3)  ·  Resistance Training (3)  ·  Alendronate (2)  ·  Dextromethorphan (2)  ·  Gentamicins (2)  ·  Methylprednisolone (2)  ·  Teriparatide (2)  ·  Testosterone (2)  ·  Transcranial Direct Current Stimulation (2)  ·  Vitamin D (2)

Sponsors

US Department of Veterans Affairs (12)  ·  VA Office of Research and Development (9)  ·  China Spinal Cord Injury Network (5)  ·  James J. Peters Veterans Affairs Medical Center (5)  ·  Brigham and Women's Hospital (4)  ·  Kessler Foundation (4)  ·  Northwestern University (4)  ·  University of British Columbia (4)  ·  Medstar Health Research Institute (3)  ·  Spaulding Rehabilitation Hospital (3)  ·  University of Miami (3)  ·  Banc de Sang i Teixits (2)  ·  Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) (2)  ·  University of Michigan (2)  ·  University of Minnesota (2)

Countries

United States (75)  ·  Canada (14)  ·  Spain (8)  ·  China (6)  ·  Switzerland (5)  ·  Australia (4)  ·  Japan (3)  ·  South Korea (3)  ·  Germany (2)  ·  India (2)  ·  Taiwan (2)  ·  United Kingdom (2)  ·  Czechia (1)  ·  Egypt (1)  ·  Hong Kong (1)

Top investigators

Nancy Rocheleau, Program Analyst (5)  ·  John Fryer, Ph.D. Asst. Director (4)  ·  Thomas J Schnitzer, MD, PhD (4)  ·  Ashraf Gorgey, PhD PT (3)  ·  William Bauman, MD (3)  ·  Christine N. Sang, MD, MPH (2)  ·  Hui Zhu, MD (2)  ·  Jeanne M Zanca, PhD, MPT (2)  ·  Jill Wecht, EdD (2)  ·  Trevor A. Dyson-Hudson, M.D. (2)  ·  Abdalla Awidi, MD (1)  ·  Abdulghani Sankari, MD PhD (1)  ·  Amit Jha, MD (1)

Results publications

PMID 21762873, PMID 30334093, PMID 10569435, PMID 15663976, PMID 16398945, PMID 17046161, PMID 17385265, PMID 17475549, PMID 17965289, PMID 19618698, PMID 19648013, PMID 19651280, PMID 19799783, PMID 19996767, PMID 20012982, PMID 20418657, PMID 20801263, PMID 21252493, PMID 21372246, PMID 21381984, PMID 21717386, PMID 21949432, PMID 22105463, PMID 22505632, PMID 23343764, PMID 23452836, PMID 23532434, PMID 23700789, PMID 23844986, PMID 24401143, PMID 24824524, PMID 24968251, PMID 24987412, PMID 26705884, PMID 27901413, PMID 28864949, PMID 28948164, PMID 29244816, PMID 30467135, PMID 30794084, PMID 30845047, PMID 31518978, PMID 32352341, PMID 32981857, PMID 33264568, PMID 33443609, PMID 34278611, PMID 34713983, PMID 35364569, PMID 35366432

NIH funding

R01NS041503 (2), 1IK2CX000547 (1), 2014 (1), 2018 (1), 2019 (1), I01RX003415 (1), R01DA030424 (1), R01HD081274 (1), R01HD093724 (1), R21HD054697 (1), R44HD108061 (1), U01HD037439 (1)